Cargando…
Long-Term Evaluation of the Use of the Transdermal Contraceptive Patch in Adolescents
The transdermal contraceptive patch, Ortho Evra™, was approved in December 2001 and released on the market in June 2002. In this study, we reviewed clinical data of young women who started the patch between June 2002 and December 2003 in the adolescent medicine clinic at a university-based outpatien...
Autores principales: | Logsdon, Stephanie, Richards, Jessica, Omar, Hatim A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
TheScientificWorldJOURNAL
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956487/ https://www.ncbi.nlm.nih.gov/pubmed/15258678 http://dx.doi.org/10.1100/tsw.2004.107 |
Ejemplares similares
-
Clinical Profiles, Occurrence, and Management of Adolescent Patients with HAIR-AN Syndrome
por: Omar, Hatim A., et al.
Publicado: (2004) -
Formulation and Evaluation of Transdermal Patch of Repaglinide
por: Prajapati, Shailesh T., et al.
Publicado: (2011) -
Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review
por: Graziottin, Alessandra
Publicado: (2008) -
Transdermal iontophoresis patch with reverse electrodialysis
por: Lee, Joon, et al.
Publicado: (2017) -
An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch
por: Zhang, Chao, et al.
Publicado: (2017)